117 related articles for article (PubMed ID: 38360074)
1. Dysfunction of CCT3-associated network signals for the critical state during progression of hepatocellular carcinoma.
Wang J; Guan X; Shang N; Wu D; Liu Z; Guan Z; Zhang Z; Jin Z; Wei X; Liu X; Song M; Zhu W; Dai G
Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167054. PubMed ID: 38360074
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
3. Molecular chaperone CCT3 supports proper mitotic progression and cell proliferation in hepatocellular carcinoma cells.
Zhang Y; Wang Y; Wei Y; Wu J; Zhang P; Shen S; Saiyin H; Wumaier R; Yang X; Wang C; Yu L
Cancer Lett; 2016 Mar; 372(1):101-9. PubMed ID: 26739059
[TBL] [Abstract][Full Text] [Related]
4. Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases.
Hou JY; Wu HY; He RQ; Lin P; Dang YW; Chen G
Pathol Res Pract; 2019 Jan; 215(1):177-194. PubMed ID: 30473171
[TBL] [Abstract][Full Text] [Related]
5. Dysfunction of PLA2G6 and CYP2C44-associated network signals imminent carcinogenesis from chronic inflammation to hepatocellular carcinoma.
Li M; Li C; Liu WX; Liu C; Cui J; Li Q; Ni H; Yang Y; Wu C; Chen C; Zhen X; Zeng T; Zhao M; Chen L; Wu J; Zeng R; Chen L
J Mol Cell Biol; 2017 Dec; 9(6):489-503. PubMed ID: 28655161
[TBL] [Abstract][Full Text] [Related]
6. m
Liu H; Jiang Y; Lu J; Peng C; Ling Z; Chen Y; Chen D; Tong R; Zheng S; Wu J
Epigenetics; 2023 Dec; 18(1):2204772. PubMed ID: 37092305
[No Abstract] [Full Text] [Related]
7. Low-Grade Dysplastic Nodules Revealed as the Tipping Point during Multistep Hepatocarcinogenesis by Dynamic Network Biomarkers.
Lu L; Jiang Z; Dai Y; Chen L
Genes (Basel); 2017 Oct; 8(10):. PubMed ID: 29027943
[TBL] [Abstract][Full Text] [Related]
8. Identifying critical states of hepatocellular carcinoma based on landscape dynamic network biomarkers.
Sun Y; Zhao H; Wu M; Xu J; Zhu S; Gao J
Comput Biol Chem; 2020 Apr; 85():107202. PubMed ID: 31951859
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of chaperonin containing TCP1 subunit 7 has diagnostic and prognostic value for hepatocellular carcinoma.
Huang X; Wang H; Xu F; Lv L; Wang R; Jiang B; Liu T; Hu H; Jiang Y
Aging (Albany NY); 2022 Jan; 14(2):747-769. PubMed ID: 35073517
[TBL] [Abstract][Full Text] [Related]
10. Dynamic network biomarker indicates pulmonary metastasis at the tipping point of hepatocellular carcinoma.
Yang B; Li M; Tang W; Liu W; Zhang S; Chen L; Xia J
Nat Commun; 2018 Feb; 9(1):678. PubMed ID: 29445139
[TBL] [Abstract][Full Text] [Related]
11. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM
Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396
[TBL] [Abstract][Full Text] [Related]
12. Role of insulin receptor substrates in the progression of hepatocellular carcinoma.
Sakurai Y; Kubota N; Takamoto I; Obata A; Iwamoto M; Hayashi T; Aihara M; Kubota T; Nishihara H; Kadowaki T
Sci Rep; 2017 Jul; 7(1):5387. PubMed ID: 28710407
[TBL] [Abstract][Full Text] [Related]
13. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
14. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.
Esparza-Baquer A; Labiano I; Sharif O; Agirre-Lizaso A; Oakley F; Rodrigues PM; Zhuravleva E; O'Rourke CJ; Hijona E; Jimenez-Agüero R; Riaño I; Landa A; La Casta A; Zaki MYW; Munoz-Garrido P; Azkargorta M; Elortza F; Vogel A; Schabbauer G; Aspichueta P; Andersen JB; Knapp S; Mann DA; Bujanda L; Banales JM; Perugorria MJ
Gut; 2021 Jul; 70(7):1345-1361. PubMed ID: 32907830
[TBL] [Abstract][Full Text] [Related]
15. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma.
Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628
[TBL] [Abstract][Full Text] [Related]
16. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
17. Hepatic NOD2 promotes hepatocarcinogenesis via a RIP2-mediated proinflammatory response and a novel nuclear autophagy-mediated DNA damage mechanism.
Zhou Y; Hu L; Tang W; Li D; Ma L; Liu H; Zhang S; Zhang X; Dong L; Shen X; Chen S; Xue R; Zhang S
J Hematol Oncol; 2021 Jan; 14(1):9. PubMed ID: 33413510
[TBL] [Abstract][Full Text] [Related]
18. CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer.
Liu Y; Zhang X; Lin J; Chen Y; Qiao Y; Guo S; Yang Y; Zhu G; Pan Q; Wang J; Sun F
Cell Death Dis; 2019 Sep; 10(9):644. PubMed ID: 31501420
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of Genomic, Epigenomic, and Transcriptomic Aberrations during Stepwise Hepatocarcinogenesis.
Jee BA; Choi JH; Rhee H; Yoon S; Kwon SM; Nahm JH; Yoo JE; Jeon Y; Choi GH; Woo HG; Park YN
Cancer Res; 2019 Nov; 79(21):5500-5512. PubMed ID: 31506333
[TBL] [Abstract][Full Text] [Related]
20. Dynamic network biomarker C1QTNF1 regulates tumor formation at the tipping point of hepatocellular carcinoma.
Yu H; Yan X; Chen G; Li R; Yang Z; Liang Z; Ye L; Chen Y; Li Y
Biomol Biomed; 2024 Mar; ():. PubMed ID: 38498315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]